Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer
City of Hope Medical Center
City of Hope Medical Center
Elicio Therapeutics
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Elevation Oncology
Intensity Therapeutics, Inc.
Alliance for Clinical Trials in Oncology
Basilea Pharmaceutica
Novo Nordisk A/S
PCI Biotech AS
National Institutes of Health Clinical Center (CC)
Mayo Clinic
University of Kentucky
National Institutes of Health Clinical Center (CC)
H. Lee Moffitt Cancer Center and Research Institute
ASLAN Pharmaceuticals
University of Wisconsin, Madison
Concordia Laboratories Inc.
National Cancer Institute (NCI)
University of Pittsburgh
Washington University School of Medicine
Wake Forest University Health Sciences
New Mexico Cancer Research Alliance
SWOG Cancer Research Network
Alliance for Clinical Trials in Oncology
SWOG Cancer Research Network
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Massachusetts General Hospital
Stanford University
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Seoul National University Hospital
National Cancer Institute (NCI)
INSYS Therapeutics Inc
Massachusetts General Hospital
Chiba University